Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1

Conditions

Hepatitis C, Chronic 3Carcinoma, Hepatocellular 2Recurrence 1Leukemia 1Hepatitis C 1Hematologic Neoplasms 1

Interventions

Ribavirin 4ledipasvir 3peginterferon alfa-2a 2ledipasvir, sofosbuvir drug combination 2Sofosbuvir 2sofosbuvir-velpatasvir drug combination 1daclatasvir 1Viusid 1Simeprevir 1Metformin 1Introns 1Dietary Supplements 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hepatitis C, Chronic × ledipasvir × Clear all
NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT03903185 2023-08-22

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Ain Shams University

Phase 1/2 Completed
24 enrolled
Other hematologic neoplasm

Hepatitis C, Leukemia, Hematologic Neoplasms, Hepatitis C, Chronic

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡